Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials Michael S. Rafii Leading Article 06 June 2020 Pages: 785 - 794
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications Emilio PeruccaMeir Bialer Leading Article 05 June 2020 Pages: 795 - 800
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review Laurent M. WillemsSebastian BauerAdam Strzelczyk Systematic Review Open access 23 July 2020 Pages: 801 - 826
Methadone for Pain Management: A Pharmacotherapeutic Review Denise KreutzwiserQutaiba A. Tawfic Review Article 20 June 2020 Pages: 827 - 839
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders Ivana ClarkDavid Taylor Review Article 27 May 2020 Pages: 841 - 852
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects Michael J. FosslerVirginia SchmithMark A. Demitrack Original Research Article Open access 16 July 2020 Pages: 853 - 865
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design Min WuCuiyun LiYanhua Ding Original Research Article 22 July 2020 Pages: 867 - 877